Clay Thorp

Affiliations

  • at Clearside Biomedical Inc. (CLSD), 2024-06-21
  • Director at Phasebio Pharmaceuticals Inc (PHAS), 2023-05-19
  • Director at Vigil Neuroscience Inc. (VIGL), 2022-05-18
  • Large Shareholder at G1 Therapeutics Inc. (GTHX), 2018-06-01
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CLSD $0.86 10,000 Director 40,522 2023-09-25 Filing
CLSD $1.02 14,000 Director 30,522 2022-12-21 Filing
VIGL $2.97 14,893 Director 1,556,030 2022-05-17 Filing
VIGL $2.76 21,802 Director 1,541,137 2022-05-16 Filing
VIGL $7.20 3,000 Director 3,000 2022-03-28 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CLSD $4.43 32,873 Director 4,951,547 2021-02-10 Filing
CLSD $4.43 32,873 Director 3,433,521 2021-02-10 Filing
PHAS $14.00 459 Large Shareholder, Director 415,959 2019-07-01 Filing
PHAS $14.00 255 Large Shareholder, Director 52,397 2019-07-01 Filing
PHAS $14.00 180 Large Shareholder, Director 162,890 2019-07-01 Filing